news & events
portfolio news
08.11.12
Jon Askaa joins Inbiomotion Board of Directors – Management team strengthened
08.11.12
TiGenix Business Update & Financial Highlights for Q3 of 2012
09.10.12
TiGenix announces publication of Cx601 Phase I/IIa study in International Journal of Colorectal Disease
25.09.12
TiGenix’s new European production facility obtains EMA approval for commercial production of ChondroCelect
20.09.12
TiGenix appoints Jean Stéphenne chairman & Russell Greig member of board of directors
24.08.12
MedLumics Names Prof. Wolfgang Drexler President of its Scientific Advisory Board
23.08.12
TiGenix Business Update & Financial Highlights for the First Half of 2012
08.08.12
TiGenix completes patient enrollment in Phase IIa rheumatoid arthritis study
17.07.12
TiGenix signs up 4th major hospital in the Netherlands for innovative cartilage repair therapy
10.07.12
TiGenix enrolls first patients in pivotal Phase III trial with lead product Cx601 in perianal fistulas
